Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma
Clinical trial NCT03900377 · COMPLETED
Trial details
- NCT number
- NCT03900377
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-09-09
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.